Molecular Imaging Predicts Risk for Abdominal Aortic Aneurysms
By MedImaging International staff writers Posted on 17 Oct 2013 |
Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research out of Europe.
The study’s findings were published in the October 2013 issue of the Journal of Nuclear Medicine. Positron emission tomography/computed tomography (PET/CT) imaging sans revealed that dense white blood cells in the outermost connective tissue in the vascular wall, increased C-reactive protein and a loss of smooth muscle cells in the middle layer of the vascular wall are all factors that may indicate future AAA rupture.
An abdominal aneurysm causes stress on the wall of the aorta, which can rupture it. Rupture of AAA is the 13th leading cause of death in western society and leads to substantial morbidity and mortality in the aging population. AAA is typically asymptomatic; therefore, it is an effective prediction of a rupture is crucial.
To determine potential markers that could be predictive of AAA rupture, researchers conducted 18F-FDG PET/CT scans on 18 patients with AAA diagnosed by ultrasound. Ten of the patients had no uptake of the 18F-FDG, while eight had positive uptake of the imaging agent. Biopsy specimens were then retrieved from each of the patients; patients with positive 18F-FDG uptake had tissue taken from both the site of the positive uptake and a distant negative site of the aortic wall.
“Our approach allows us—for the first time to our knowledge—to analyze spots of high 18F-FDG uptake and compare them to a distant inactive zone of the same aneurysm. We further compared these biopsies to fragments collected in patients with negative 18F-FDG uptake. This strategy allowed for the discrimination of biologic alterations associated with 18F-FDG uptake that would help identify relevant biologic markers predictive of rupture,” said Audrey Courtois, PhD, from the laboratory of connective tissues biology, GIGA-R, University of Liège (Belgium), and lead author of the study.
The tissue from the area of positive 18F-FDG uptake were characterized by an increased number of inflammatory cells in the outermost connective tissue, a high level of C-reactive protein and an extreme decrease in smooth muscle cells, as compared to the biopsies from areas of no uptake. Furthermore, an increase in several matrix metalloproteinase enzymes was seen in the tissue with positive 18F-FDG uptake.
“These data suggest that a PET scan with positive 18F-FDG uptake provide diagnostic support to proceed without delay to aneurysm surgery, despite a person’s age or operative risk. However, the absence of FDG uptake at the level of the aneurismal aortic wall can help us make a safe decision to avoid unnecessary surgery and decrease the burden of healthcare costs,” concluded Dr. Courtois. “This 18F-FDG PET/CT study, with an arterial phase CT, allows us to fully characterize the disease, including the conventional risk factors such as the size of the aneurysm. Although much of the current research is being conducted in the field of oncology, the current study further strengthens 18F-FDG PET/CT as a decisive tool in the management of inflammatory disorders.”
Related Links:
University of Liège
The study’s findings were published in the October 2013 issue of the Journal of Nuclear Medicine. Positron emission tomography/computed tomography (PET/CT) imaging sans revealed that dense white blood cells in the outermost connective tissue in the vascular wall, increased C-reactive protein and a loss of smooth muscle cells in the middle layer of the vascular wall are all factors that may indicate future AAA rupture.
An abdominal aneurysm causes stress on the wall of the aorta, which can rupture it. Rupture of AAA is the 13th leading cause of death in western society and leads to substantial morbidity and mortality in the aging population. AAA is typically asymptomatic; therefore, it is an effective prediction of a rupture is crucial.
To determine potential markers that could be predictive of AAA rupture, researchers conducted 18F-FDG PET/CT scans on 18 patients with AAA diagnosed by ultrasound. Ten of the patients had no uptake of the 18F-FDG, while eight had positive uptake of the imaging agent. Biopsy specimens were then retrieved from each of the patients; patients with positive 18F-FDG uptake had tissue taken from both the site of the positive uptake and a distant negative site of the aortic wall.
“Our approach allows us—for the first time to our knowledge—to analyze spots of high 18F-FDG uptake and compare them to a distant inactive zone of the same aneurysm. We further compared these biopsies to fragments collected in patients with negative 18F-FDG uptake. This strategy allowed for the discrimination of biologic alterations associated with 18F-FDG uptake that would help identify relevant biologic markers predictive of rupture,” said Audrey Courtois, PhD, from the laboratory of connective tissues biology, GIGA-R, University of Liège (Belgium), and lead author of the study.
The tissue from the area of positive 18F-FDG uptake were characterized by an increased number of inflammatory cells in the outermost connective tissue, a high level of C-reactive protein and an extreme decrease in smooth muscle cells, as compared to the biopsies from areas of no uptake. Furthermore, an increase in several matrix metalloproteinase enzymes was seen in the tissue with positive 18F-FDG uptake.
“These data suggest that a PET scan with positive 18F-FDG uptake provide diagnostic support to proceed without delay to aneurysm surgery, despite a person’s age or operative risk. However, the absence of FDG uptake at the level of the aneurismal aortic wall can help us make a safe decision to avoid unnecessary surgery and decrease the burden of healthcare costs,” concluded Dr. Courtois. “This 18F-FDG PET/CT study, with an arterial phase CT, allows us to fully characterize the disease, including the conventional risk factors such as the size of the aneurysm. Although much of the current research is being conducted in the field of oncology, the current study further strengthens 18F-FDG PET/CT as a decisive tool in the management of inflammatory disorders.”
Related Links:
University of Liège
Latest Nuclear Medicine News
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
Channels
Radiography
view channel
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read moreMRI
view channel
Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
Aortic stenosis is a common and potentially life-threatening heart condition. It occurs when the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes stiff and narrow.... Read more
New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more
AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreGeneral/Advanced Imaging
view channel
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read more
CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
Medical imaging, such as computed tomography (CT) scans, plays a crucial role in oncology, offering essential data for cancer detection, treatment planning, and monitoring of response to therapies.... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more